Research and Markets: Global Irritable Bowel Syndrome Market 2015-2019: Key Vendors are Actavis, Astellas Pharma, Nestle and Takeda Pharmaceutical

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/wq3rtp/global_irritable) has announced the addition of the "Global Irritable Bowel Syndrome Market 2015-2019" report to their offering.

One major trend upcoming in this market is an increase in public awareness about irritable bowel syndrome, which is expected to increase the number of treatment-seeking patients, thereby increasing the consumption of medications. Growing public awareness increases the number of treatment-seeking patients, thereby leading to increased consumption of approved medications.

According to the report, the presence of huge unmet needs in the field of irritable bowel syndrome is one of the major drivers of the market. There is a lack of a significant number of drugs approved by the FDA, and the use of generics and off-label drugs causes erosion in the market share of labeled products. This provides vendors with an opportunity to produce new drugs, which can give them an edge over others and hence, grab a major portion of the market.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Product Profiles

05. Market Research Methodology

06. Introduction

07. Market Landscape

08. Market Segmentation by Mechanism of Action

09. Market Segmentation by Dosage Form

10. Market Segmentation by Indication

11. Market Segmentation by End User Gender

12. Geographical Segmentation

13. Rate of Incidence and Prevalence

14. Buying Criteria

15. Market Growth Drivers

16. Drivers and their Impact

17. Market Challenges

18. Impact of Drivers and Challenges

19. Market Trends

20. Trends and their Impact

21. Vendor Landscape

22. Pipeline Portfolio

23. Key Vendor Analysis

24. Other Reports in this Series

Companies Mentioned:

  • Abbott
  • Actavis
  • Alba Therapeutics
  • Alfa Wassermann
  • Alizyme
  • Almirall
  • AltheRx
  • Ardelyx
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Bristol Myers Squibb
  • Dainippon Sumitomo Pharma
  • Dong-A Socio Holdings
  • DraisPharmaceuticals
  • Dynogen
  • GlaxoSmithKline
  • Hanmi
  • ImmusanT
  • Ironwood
  • Janssen
  • Lexicon
  • Menarini
  • MicroDose Therapeutx
  • Nestle
  • Norgine
  • Novartis
  • Ocera Therapeutics
  • Ono Pharmaceutical
  • ParPharmaceutical

For more information visit http://www.researchandmarkets.com/research/wq3rtp/global_irritable

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals